Cargando…
Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838630/ https://www.ncbi.nlm.nih.gov/pubmed/35202561 http://dx.doi.org/10.1164/rccm.202112-2788LE |
_version_ | 1784869325209862144 |
---|---|
author | Duijts, Liesbeth Fleming, Louise J. Bacharier, Leonard B. Pitrez, Paulo M. Reddel, Helen K. |
author_facet | Duijts, Liesbeth Fleming, Louise J. Bacharier, Leonard B. Pitrez, Paulo M. Reddel, Helen K. |
author_sort | Duijts, Liesbeth |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9838630 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Thoracic Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-98386302023-01-17 Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment Duijts, Liesbeth Fleming, Louise J. Bacharier, Leonard B. Pitrez, Paulo M. Reddel, Helen K. Am J Respir Crit Care Med Correspondence American Thoracic Society 2022-02-24 /pmc/articles/PMC9838630/ /pubmed/35202561 http://dx.doi.org/10.1164/rccm.202112-2788LE Text en Copyright © 2022 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . For commercial usage and reprints, please e-mail Diane Gern (dgern@thoracic.org). |
spellingShingle | Correspondence Duijts, Liesbeth Fleming, Louise J. Bacharier, Leonard B. Pitrez, Paulo M. Reddel, Helen K. Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment |
title | Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment |
title_full | Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment |
title_fullStr | Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment |
title_full_unstemmed | Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment |
title_short | Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment |
title_sort | reply to baraldi and piacentini: global initiative for asthma 2021: asthma in preschool children and short-acting β(2)-agonist–only treatment |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838630/ https://www.ncbi.nlm.nih.gov/pubmed/35202561 http://dx.doi.org/10.1164/rccm.202112-2788LE |
work_keys_str_mv | AT duijtsliesbeth replytobaraldiandpiacentiniglobalinitiativeforasthma2021asthmainpreschoolchildrenandshortactingb2agonistonlytreatment AT fleminglouisej replytobaraldiandpiacentiniglobalinitiativeforasthma2021asthmainpreschoolchildrenandshortactingb2agonistonlytreatment AT bacharierleonardb replytobaraldiandpiacentiniglobalinitiativeforasthma2021asthmainpreschoolchildrenandshortactingb2agonistonlytreatment AT pitrezpaulom replytobaraldiandpiacentiniglobalinitiativeforasthma2021asthmainpreschoolchildrenandshortactingb2agonistonlytreatment AT reddelhelenk replytobaraldiandpiacentiniglobalinitiativeforasthma2021asthmainpreschoolchildrenandshortactingb2agonistonlytreatment |